Log in

8049 Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. HKEX · China

Jilin Province Huinan Changlong Bio Pharmacy Co. (8049) news

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8049, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Jilin Province Huinan Changlong Bio Pharmacy Co. news

We have not published a story on Jilin Province Huinan Changlong Bio Pharmacy Co. yet. When there is news, it will appear here.

Questions about Jilin Province Huinan Changlong Bio Pharmacy Co.

What is the ticker symbol of Jilin Province Huinan Changlong Bio Pharmacy Co.?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. trades under the ticker 8049 on HKEX.

Where is Jilin Province Huinan Changlong Bio Pharmacy Co. listed?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. is listed on HKEX.

Which country or territory is Jilin Province Huinan Changlong Bio Pharmacy Co. listed under?

Our directory records Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. under China.

What does Jilin Province Huinan Changlong Bio Pharmacy Co. do?

Our directory classifies Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Jilin Province Huinan Changlong Bio Pharmacy Co.?

The ISIN recorded for Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. is CNE100000130.

Does aibio.space cover Jilin Province Huinan Changlong Bio Pharmacy Co.?

aibio.space lists Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Jilin Province Huinan Changlong Bio Pharmacy Co.?

Companies in our directory listed in the same country and business area as Jilin Province Huinan Changlong Bio Pharmacy Co.: Tibet Cheezheng Tibetan Medicine Co., Sihuan Pharmaceutical Holdings Group, NOVAST LABORATORIES LTD, Dong-E-E-Jiao Co., Guangdong Jiaying Pharmaceutical Co., GuangYuYuan Chinese Herbal Medicine Co..

Investor discussion: Jilin Province Huinan Changlong Bio Pharmacy Co.

Members talk about Jilin Province Huinan Changlong Bio Pharmacy Co. (8049). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Jilin Province Huinan Changlong Bio Pharmacy Co., newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS. Source

  2. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS. Source

  3. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

  4. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

  5. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

  6. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

  7. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

Press releases

Headlines of Jilin Province Huinan Changlong Bio Pharmacy Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    THE PASSING OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGES IN COMPOSITION OF BOARD COMMITTEES

  2. HKEXnews

    DISCLOSEABLE TRANSACTIONS SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS

  3. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  4. HKEXnews

    (REVISED) PROPOSED DECLARATION AND PAYMENT OF A SPECIAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS

  5. HKEXnews

    POLL RESULTS AT THE EXTRAORDINARY GENERAL MEETING HELD ON 9 JUNE 2026 AND SPECIAL DIVIDEND PAYMENT

  6. HKEXnews

    POLL RESULTS AT THE 2025 ANNUAL GENERAL MEETING HELD ON 9 JUNE 2026

  7. HKEXnews

    REVISED NOTICE OF ANNUAL GENERAL MEETING

  8. HKEXnews

    ANNOUNCEMENT (1) WITHDRAWAL OF ORIGINAL ORDINARY RESOLUTION NO. 10 AND ADDITIONAL RESOLUTION TO BE PROPOSED AT THE AGM; AND (2) REVISED NOTICE OF AGM AND REVISED PROXY FORM

  9. HKEXnews

    CLARIFICATION ANNOUNCEMENT

  10. HKEXnews

    PROPOSED DECLARATION AND PAYMENT OF A SPECIAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS

  11. HKEXnews

    REPLY SLIP FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 9 JUNE 2026

  12. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  13. HKEXnews

    PROPOSED DECLARATION AND PAYMENT OF A SPECIAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS

  14. HKEXnews

    REPLY SLIP FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 9 JUNE 2026

  15. HKEXnews

    Proxy Form for 2025 Annual General Meeting to be held on 9 June 2026 (or at any adjournment thereof)

  16. HKEXnews

    ANNOUNCEMENT AND NOTICE OF ANNUAL GENERAL MEETING

  17. HKEXnews

    2025 ANNUAL RESULTS ANNOUNCEMENT

  18. HKEXnews

    DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS

  19. HKEXnews

    DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS

  20. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:8049 on TradingView.

Listing details

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8049, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Ticker
8049
Listing
HKEX
Country or territory
China
Business scope
Biopharma / pharmaceutical profile checked
ISIN
CNE100000130
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.